MWA
BSX icon

Medallion Wealth Advisors’s Boston Scientific BSX Stock Holding History

Medallion Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Sell
18
-24
-57% -$1.92K ﹤0.01% 1051
2025
Q4 		$4K Hold
42
– – ﹤0.01% 903
2025
Q3 		$4.1K Hold
42
– – ﹤0.01% 885
2025
Q2 		$4.4K Hold
42
– – ﹤0.01% 852
2025
Q1 		$4.25K Hold
42
– – ﹤0.01% 813
2024
Q4 		$3.75K Buy
+42
New +$3.7K ﹤0.01% 777

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Medallion Wealth Advisors's BSX Position: Q1 2026 in Review

Medallion Wealth Advisors reduced its Boston Scientific (BSX) stake by 57% in Q1 2026, selling an estimated $1.92K and leaving 18 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Medallion Wealth Advisors first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.4K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Medallion Wealth Advisors held 18 shares of Boston Scientific worth $1.13K as of Q1 2026.
  • Medallion Wealth Advisors sold 24 Boston Scientific shares in Q1 2026, an estimated $1.92K.
  • Boston Scientific made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q1 2026, its #1051 holding.
  • Medallion Wealth Advisors first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Medallion Wealth Advisors's Boston Scientific position peaked at $4.4K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.